sábado, 21 de octubre de 2023

FDA expands pediatric indication for entrectinib and approves new pellet formulation

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-expands-pediatric-indication-entrectinib-and-approves-new-pellet-formulation

No hay comentarios:

Publicar un comentario